Transcriptional pathways and potential therapeutic targets in the regulation of Ncx1 expression in cardiac hypertrophy and failure

Advances in Experimental Medicine and Biology

Volumn 961, Issue , 2013, Pages 125-135

  Menick, Donald R ^a   Li, Mona S ^a   Chernysh, Olga ^a   Renaud, Ludivine ^a   Kimbrough, Denise ^a   Kasiganesan, Harinath ^a   Mani, Santhosh K ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

HDAC; Transcriptional regulation; Adrenergic; Adrenergic

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; 2 [4 (2,5 DIFLUOROBENZYLOXY)PHENOXY] 5 ETHOXYANILINE; ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE INHIBITOR; ION TRANSPORT AFFECTING AGENT; SERUM RESPONSE FACTOR; SN 6; SODIUM CALCIUM EXCHANGE PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR NKX2.5; TRICHOSTATIN A; UNCLASSIFIED DRUG;

CONFERENCE PAPER; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; NCX1 GENE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 84873589483     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-4756-6_11     Document Type: Conference Paper

References (65)

1. 2+ cycling proteins underlie cardiac action potential prolongation in a pressure-overloaded guinea pig model with cardiac hypertrophy and failure. Circ. Res. 86, 558-570 (2000)
2. M.E. Anderson, Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias? Trends Cardiovasc. Med. 14, 152-161 (2004)
3. K.V. Barnes, M.M. Dawson, D.R. Menick, Initial characterization of the feline sodium-calcium exchanger gene. Ann. N. Y. Acad. Sci. 779, 121-125 (1996)
4. K.V. Barnes, G. Cheng, M.M. Dawson, D.R. Menick, Cloning of cardiac, kidney, and brain promoters of the feline ncx1 gene. J. Biol. Chem. 272, 11510-11517 (1997)
5. R.A. Bassani, D.M. Bers, Na-Ca exchange is required for rest-decay but not for rest-potentiation of twitches in rabbit and rat ventricular myocytes. J. Mol. Cell. Cardiol. 26, 1335-1347 (1994)
6. D.M. Bers, Cardiac excitation-contraction coupling. Nature 415, 198-205 (2002)
7. D.M. Bers, J.H. Bridge, Relaxation of rabbit ventricular muscle by Na-Ca exchange and sarcoplasmic reticulum calcium pump. Ryanodine and voltage sensitivity. Circ. Res. 65, 334-342 (1989)
8. D.M. Bers, W.J. Lederer, J.R. Berlin, Intracellular Ca transients in rat cardiac myocytes: role of Na-Ca exchange in excitation-contraction coupling. Am. J. Physiol. 258, C944-C954 (1990)
9. M.R. Bristow, Beta-adrenergic receptor blockade in chronic heart failure. Circulation 101, 558-569 (2000)
10. 2+ exchanger gene. J. Biol. Chem. 274, 12819-12826 (1999)
11. 2+ exchanger expression in rat cardiac myocytes. J. Mol. Cell. Cardiol. 32, 611-620 (2000)
12. K.L. Golden, J. Ren, J. O'Connor, A. Dean, S.E. DiCarlo, J.D. Marsh, In vivo regulation of Na/Ca exchanger expression by adrenergic effectors. Am. J. Physiol. Heart Circ. Physiol. 280, H1376-H1382 (2001)
13. 2+ -ATPase in failing and nonfailing human myocardium. Circ. Res. 75, 434-442 (1994)
14. G, Hasenfuss, M. Preuss, S. Lehnart, J. Prestle, M. Meyer, H. Just, Relationship between diastolic function and protein levels of sodium-calcium-exchanger in end-stage failing human hearts. Circulation 94, I-443 (1996)
15. G. Hasenfuss, M. Meyer, W. Schillinger, M. Preuss, B. Pieske, H. Just, Calcium handling proteins in the failing human heart. Basic Res. Cardiol. 92, 87-93 (1997)
16. 2+ -exchanger protein levels and diastolic function of failing human myocardium. Circulation 99, 641-648 (1999)
17. 2+ exchange activity in canine pacing-induced heart failure. Circ. Res. 87, 690-698 (2000)
18. I.A. Hobai, C. Maack, B. O'Rourke, Partial inhibition of sodium/calcium exchange restores cellular calcium handling in canine heart failure. Circ. Res. 95, 292-299 (2004)
19. 2+ /calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ. Res. 84, 713-721 (1999)
20. 2+ /calmodulin-dependent protein kinases of cardiac sarcoplasmic reticulum. Basic Res. Cardiol. 92 (Suppl 1), 37-43 (1997)
21. 2+ exchanger in response to cardiac pressure overload. Am. J. Physiol. 265, H1024-H1029 (1993)
22. 2+ exchanger type 1 in renal epithelial cells. J. Cardiovasc. Pharmacol. 44 (Suppl 1), S239-S243 (2004)
23. P. Kofuji, W.J. Lederer, D.H. Schulze, Na/Ca exchanger isoforms expressed in kidney. Am. J. Physiol. 265, F598-F603 (1993)
24. S.V. Koushik, J. Bundy, S.J. Conway, Sodium-calcium exchanger is initially expressed in a heart-restricted pattern within the early mouse embryo. Mech. Dev. 88, 119-122 (1999)
25. H.R. Lee, S.A. Henderson, R. Reynolds, P. Dunnmon, D. Yuan, K.R. Chien, Alpha 1-adrenergic stimulation of cardiac gene transcription in neonatal rat myocardial cells. Effects on myosin light chain-2 gene expression. J. Biol. Chem. 263, 7352-7358 (1988)
26. 2+ exchanger isoforms. J. Biol. Chem. 269, 14849-14852 (1994)
27. 2+ -ATPase activity in guinea pig ventricles. J. Biol. Chem. 258, 464-471 (1983)
28. 2+ exchange in the infarcted heart. Implications for excitation-contraction coupling. Circ. Res. 81, 1083-1093 (1997)
29. B.D. Lowes, E.M. Gilbert, W.T. Abraham, W.A. Minobe, P. Larrabee, D. Ferguson, E.E. Wolfel, J. Lindenfeld, T. Tsvetkova, A.D. Robertson, R.A. Quaife, M.R. Bristow, Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N. Engl. J. Med. 346, 1357-1365 (2002)
30. A.C. MacDonald, S.E. Howlett, Differential effects of the sodium calcium exchange inhibitor, KB-R7943, on ischemia and reperfusion injury in isolated guinea pig ventricular myocytes. Eur. J. Pharmacol. 580, 214-223 (2008)
31. L.S. Maier, D.M. Bers, Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond. J. Mol. Cell. Cardiol. 34, 919-939 (2002)
32. S.K. Mani, E.A. Egan, B.K. Addy, M. Grimm, H. Kasiganesan, T. Thiyagarajan, L. Renaud, J.H. Brown, C.B. Kern, D.R. Menick, Beta-adrenergic receptor stimulated Ncx1 upregulation is mediated via a CaMKII/AP-1 signaling pathway in adult cardiomyocytes. J. Mol. Cell. Cardiol. 48, 342-351 (2010)
33. T.A. McKinsey, Therapeutic potential for HDAC inhibitors in the heart. Annu. Rev. Pharmacol. Toxicol. 10, 303-319 (2012)
34. D.R. Menick, K.V. Barnes, U.F. Thacker, M.M. Dawson, D.E. McDermott, J.D. Rozich, R.L. Kent, G. Cooper IV, The exchanger and cardiac hypertrophy. Ann. N. Y. Acad. Sci. 779, 489-501 (1996)
35. S. Minucci, P.G. Pelicci, Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 6, 38-51 (2006)
36. J.D. Molkentin, G.W. Dorn 2nd, Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu. Rev. Physiol. 63, 391-426 (2001)
37. 2+ exchanger gene H1-promoter in a transgenic mouse model. Circ. Res. 90, 158-164 (2002)
38. 2+ exchanger gene. Am. J. Physiol. 274, H217-H232 (1998)
39. 2+ exchange inhibitor in guinea pig cardiac ventricular myocytes. Eur. J. Pharmacol. 573, 161-169 (2007)
40. I. Nusinzon, C.M. Horvath, Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation. Mol. Cell. Biol. 26, 3106-3113 (2006)
41. B. O'Rourke, The ins and outs of calcium in heart failure. Circ. Res. 102, 1301-1303 (2008)
42. 2+ load attributable to the predominance of forward mode block. Circ. Res. 102, 1398-1405 (2008)
43. 2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ. Res. 85, 1009-1019 (1999)
44. S.M. Pogwizd, K. Schlotthauer, L. Li, W. Yuan, D.M. Bers, Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward recti fi er potassium current, and residual beta-adrenergic responsiveness. Circ. Res. 88, 1159-1167 (2001)
45. Y. Qiu, Y. Zhao, M. Becker, S. John, B.S. Parekh, S. Huang, A. Hendarwanto, E.D. Martinez, Y. Chen, H. Lu, N.L. Adkins, D.A. Stavreva, M. Wiench, P.T. Georgel, R.L. Schiltz, G.L. Hager, HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol. Cell 22, 669-679 (2006)
46. 2+ exchanger isoforms NCX1, NCX2, and NCX3 in rat. Am. J. Physiol. 272, C1250-C1261 (1997)
47. 2+ -exchanger overexpression on excitation-contraction coupling in adult rabbit ventricular myocytes. J. Mol. Cell. Cardiol. 34, 389-400 (2002)
48. B.A. Rothermel, T.A. McKinsey, R.B. Vega, R.L. Nicol, P. Mammen, J. Yang, C.L. Antos, J.M. Shelton, R. Bassel-Duby, E.N. Olson, R.S. Williams, Myocyteenriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. U.S.A. 98, 3328-3333 (2001)
49. J. Sadoshima, S. Izumo, Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fi broblasts. Critical role of the AT1 receptor subtype. Circ. Res. 73, 413-423 (1993a)
50. J. Sadoshima, S. Izumo, Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipidderived second messengers. Circ. Res. 73, 424-438 (1993b)
51. 2+ exchanger. Circ. Res. 87, 581-587 (2000)
52. K.R. Sipido, P.G. Volders, M.A. Vos, F. Verdonck, Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: A new target for therapy? Cardiovasc. Res. 53, 782-805 (2002)
53. 2+ exchanger in end-stage human heart failure. Circ. Res. 75, 443-453 (1994)
54. 2+ exchanger in postnatal development of the rat, in experimental-induced cardiac hypertrophy and in the failing human heart. Basic Res. Cardiol. 92, 53-58 (1997)
55. C.C. Sucharov, P.D. Mariner, K.R. Nunley, C. Long, L. Leinwand, M.R. Bristow, A beta1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction. Am. J. Physiol. Heart Circ. Physiol. 291, H1299-H1308 (2006)
56. T. Takasago, T. Imagawa, M. Shigekawa, Phosphorylation of the cardiac ryanodine receptor by cAMP-dependent protein kinase. J. Biochem. 106, 872-877 (1989)
57. T. Tobimatsu, H. Fujisawa, Tissue-speci fi c expression of four types of rat calmodulin-dependent protein kinase II mRNAs. J. Biol. Chem. 264, 17907-17912 (1989)
58. S.F. Vatner, D.E. Vatner, C.J. Homcy, Beta-adrenergic receptor signaling: An acute compensatory adjustmentinappropriate for the chronic stress of heart failure? Insights from Gsalpha overexpression and other genetically engineered animal models. Circ. Res. 86, 502-506 (2000)
59. + channels. J. Clin. Invest. 116, 3127-3138 (2006)
60. 2+ ATPase transport capacity regulates the contractility of normal and hypertrophied feline ventricular myocytes. J. Card. Fail. 11, 380-387 (2005)
61. 2+ exchanger expression in adult cardiomyocytes. J. Mol. Cell. Cardiol. 38, 735-743 (2005)
62. L. Xu, L. Renaud, J.G. Muller, C.F. Baicu, D.D. Bonnema, H. Zhou, C.S. Kappler, S.W. Kubalak, M.R. Zile, S.J. Conway, D.R. Menick, Regulation of Ncx1 expression. Identi fication of regulatory elements mediating cardiac-speci fi c expression and up-regulation. J. Biol. Chem. 281, 34430-34440 (2006)
63. X.J. Yang, S. Gregoire, Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol. Cell. Biol. 25, 2873-2884 (2005)
64. T. Zhang, L.S. Maier, N.D. Dalton, S. Miyamoto, J. Ross Jr., D.M. Bers, J.H. Brown, The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ. Res. 92, 912-919 (2003)
65. G. Zupkovitz, J. Tischler, M. Posch, I. Sadzak, K. Ramsauer, G. Egger, R. Grausenburger, N. Schweifer, S. Chiocca, T. Decker, C. Seiser, Negative and positive regulation of gene expression by mouse histone deacetylase 1. Mol. Cell. Biol. 26, 7913-7928 (2006)